Advanced Solid Tumors: CXCR4 PET Tracer Study

We are testing a new radiopharmaceutical to see how it works in patients with advanced solid tumors. This study aims to understand its effects on the body and how it can help in future treatments.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
IRCCS Istituto Nazionale Tumori Fondazione Pascale
Nuclear Medicine Unit
Soccavo, Italy
Sponsor: IRCCS Istituto Nazionale Tumori Fondazione Pascale
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.